Stockreport

How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Capital And GraftAssureDx Milestones [Yahoo! Finance]

Insight Molecular Diagnostics Inc.  (IMDX) 
PDF The updated analyst narrative on Insight Molecular Diagnostics now centers on a fresh price target of $12 per share, while the internal fair value estimate remains at $ [Read more]